1. bookVolume 29 (2021): Issue 2 (April 2021)
Journal Details
First Published
08 Aug 2013
Publication timeframe
4 times per year
access type Open Access

Frequency, Distribution and Genotyping of Malassezia Species in Patients with Psoriasis vulgaris

Published Online: 27 Apr 2021
Page range: 217 - 227
Received: 20 Aug 2020
Accepted: 14 Jan 2021
Journal Details
First Published
08 Aug 2013
Publication timeframe
4 times per year

Background: Malassezia species are reported to play a role in the etiology of Psoriasis vulgaris.

Objective: The aim of this study was to determine the presence, frequency, distribution, and genotyping of skin colonization of Malassezia species in Psoriasis vulgaris and to compare with healthy individuals and to investigate its relationship with the severity of the disease.

Methods: Skin samples were taken from scalp, arm, body, and leg of 34 psoriasis patients (lesional/non-lesional skin) and 30 healthy volunteers. Overall, 392 skin scraping samples were taken for the isolation of Malassezia species, which were incubated on the modified-Dixon agar. Conventional culture methods were used for Malassezia species identification. In isolates, genotyping was carried out by PCR-RFLP method.

Results: In the samples from psoriatic lesions, most frequently isolated Malassezia species were M.globosa and M.furfur. Similarly, the most frequently isolated species in healthy volunteers was M. globosa; followed by M.restricta and M.sympodialis. The M.furfur isolation rate in psoriatic scalp and leg lesions of the patients was significantly higher than in healthy volunteers. There was no relationship between the severity of the disease and the isolated species.

Conclusion: It was found that there was a difference between patients with psoriasis and healthy controls regarding presence and frequency of Malassezia species. Therefore, our study results support the view that Malessezia species may be associated with the etiopathogenesis of psoriasis. In addition, we surmise that the treatment applications for the regulation of skin microbiota of psoriasis patients will contribute positively to the treatment of psoriasis.


1. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 2020 May 19;323(19):1945-60. DOI: 10.1001/jama.2020.4006Search in Google Scholar

2. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018 Nov;(5S):18-20.Search in Google Scholar

3. Takemoto A, Cho O, Morohoshi Y, Sugita T, Muto M. Molecular characterization of the skin fungal microbiome in patients with psoriasis. J Dermatol. 2015 Feb;42(2):166-70. DOI: 10.1111/1346-8138.12739Search in Google Scholar

4. Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol. 2019 Mar-Apr;37(2):160-6. DOI: 10.1016/j. clindermatol.2019.01.011Search in Google Scholar

5. Zomorodian K, Mirhendi H, Tarazooie B, Zeraati H, Hallaji Z, Balighi K. Distribution of Malassezia species in patients with psoriasis and healty individuals in Tehran, Iran. J Cutan Pathol. 2008 Nov; 35811:1027-31. DOI: 10.1111/j.1600-0560.2007.00968.xSearch in Google Scholar

6. Benhadou F, Mintoff D, Schnebert B, Thio HB. Psoriasis and microbiota: A systematic review. Diseases. 2018 Jun;6(2):47. DOI: 10.3390/diseases6020047Search in Google Scholar

7. Lober CW, Belew PW, Rosenberg EW, Bale G. Patch tests with killed sonicated microflora in patients with psoriasis. Arch Dermatol. 1982 May;118(5):322-5. DOI: 10.1001/archderm.118.5.322Search in Google Scholar

8. Narang T, Dogra S, Kaur I, Kanwar AJ. Malassezia and psoriasis: Koebner’s phenomenon or direct causation? J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1111-2. DOI: 10.1111/j.1468-3083.2006.02097.xSearch in Google Scholar

9. Bunse T, Mahrle G. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients. Acta Derm Venereol. 1996 Jan;76(1):10-2.Search in Google Scholar

10. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012 Jan;25(1):106-41. DOI: 10.1128/CMR.00021-11Search in Google Scholar

11. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002 Jan;15:21-57. DOI: 10.1128/CMR.15.1.21-57.2002Search in Google Scholar

12. Ertam I, Aytimur D. Malassezia spp. ve Dermatoloji’deki Yeri. Turkderm. 2006;40(1):7-10.Search in Google Scholar

13. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004 Nov;51(5):785-98. DOI: 10.1016/j.jaad.2003.12.034Search in Google Scholar

14. Kantarcioglu AS, Yucel A. Malassezia türleri: taksonomi, mikoloji, immünoloji, patogenez, vücuttaki dağılımı ve ilişkili infeksiyonlar, laboratuvar tanımı, antifungallere duyarlılığı. Cerrahpaşa J Med. 2005;36:134-54.Search in Google Scholar

15. Rodoplu G, Saracli MA, Gumral R, Yildiran ST. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. Journal de Mycologie Medicale. 2014 June;24(2):117-23. DOI: 10.1016/j.mycmed.2014.02.001Search in Google Scholar

16. Midgley G, Gueho E, Guillot J. Disease caused by Malassezia species. Topley and Wilson’s Microbiology and microbial infections. 9th edition. Edited by: Ajello L, Hay RJ. London: Arnold 1998;4:201-11.Search in Google Scholar

17. Bayraktar S, Duran N, Duran GG, Eryilmaz N, Aslan H, Onlen C, et al. Identification of medically important Candida species by polymerase chain reaction-restriction fragment length polymorphism analysis of the rDNA ITS1 and ITS2 regions. Indian J Med Microbiol. 2017 Oct-Dec;35(4):535-42. DOI: 10.4103/ijmm. IJMM_17_102Search in Google Scholar

18. Thomas DS, Ingham E, Bojar RA, Holland KT. In vitro modulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Micro-biol. 2008 Nov;54(2):203-14. DOI: 10.1111/j.1574-695X.2008.00468.xSearch in Google Scholar

19. Kesavan S, Holland KT, Ingham E. The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro. Med Mycol. 2000 Jun;38(3):239-47. DOI: 10.1080/mmy. in Google Scholar

20. Belew PW, Rosenberg EW, Jennings BR. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale). Mycopathologia. 1980;70(3):187-91. DOI: 10.1007/BF00443030Search in Google Scholar

21. Squiquera L, Galimberti R, Morelli L, Plotkin L, Milicich R, Kowalckzuk A, et al. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol. 1994 Jul;19(4):289-93. DOI: 10.1111/j.1365-2230.1994.tb01197.xSearch in Google Scholar

22. Aydogan K, Tore O, Akcaglar S, Oral B, Ener B, Tunalı S, et al. Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis. Int J Dermatol. 2013 Jan;52(1):46-52. DOI: 10.1111/j.1365-4632.2011.05280.xSearch in Google Scholar

23. Baroni A, Paolett I, Ruocc E, Agozzin M, Tufan MA, Donnarumma G. Possible role of Malassezia furfur in psoriasis: modulation of TGF- β1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J Cutan Pathol. 2004 Jan;31(1):35-42. DOI: 10.1046/j.0303-6987.2004.0135.xSearch in Google Scholar

24. Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, et al. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res. 2006 Jan;297(7):280-8. DOI: 10.1007/s00403-005-0594-4Search in Google Scholar

25. Plotkin LI, Mathov I, Squiquera L, Leoni J. Arachidonic acid released from epithelial cells by Malassezia furfur phospholipase A2: a potential pathophysio-logic mechanism. Mycologia. 1998;90:163-9. DOI: 10.1080/00275514.1998.12026895Search in Google Scholar

26. Brunke S, Hube B. MfLIP1, a gene encoding an extra-cellular lipase of the lipid-dependent fungus Malassezia furfur. Microbiology. 2006 Feb;152:547-54. DOI: 10.1099/mic.0.28501-0Search in Google Scholar

27. Oh BH, Song YC, Lee YW, Choe YB, Ahn KJ. Comparison of Nested PCR and RFLP for Identification and Classification of Malassezia Yeasts from Healthy Human Skin. Ann Dermatol. 2009 Nov;21(4):352-7. DOI: 10.5021/ad.2009.21.4.352Search in Google Scholar

28. Prohic A. Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healty subjects. Acta Dermatovenerol Croat. 2003;11(1):10-6.Search in Google Scholar

29. Takahata Y, Sugita T, Hiruma M, Muto M. Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay. Br J Dermatol. 2007 Oct;157(4):670-3. DOI: 10.1111/j.1365-2133.2007.08090.xSearch in Google Scholar

30. Paulino L, Tseng C, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 2008;8:460-71. DOI: 10.1111/j.1567-1364.2008.00359.xSearch in Google Scholar

31. Gomez-Moyano E, Crespo-Erchiga V, Martínez-Pilar L, Godoy Diaz D, Martínez- Garcia S, Lova Navarro M, et al. Do Malassezia species play a role in exacerbation of scalp psoriasis? J Mycol Med. 2014 Jun;24(2):87-92. DOI: 10.1016/j.mycmed.2013.10.007Search in Google Scholar

32. Tarazooie B, Kordbacheh P, Zaini F, Zomorodian K, Saadat F, Zeraati H, et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healty individuals in Tehran, Iran. BMC Dermatol. 2004 May;4:5. DOI: 10.1186/1471-5945-4-5Search in Google Scholar

33. Gupta AK, Kohli Y, Summerball RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol. 2001 Jun;39(3):243-51. DOI: 10.1080/714031025Search in Google Scholar

34. Jagielski T, Rup E, Ziółkowska A, Roeske K, Macura AB, Bielecki J. Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods. BMC Dermatol. 2014 Mar;14:3. DOI: 10.1186/1471-5945-14-3Search in Google Scholar

35. Tett A, Pasolli E, Farina S, Truong DT, Ascinar F, Zolfo M, et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ Biofilms Microbiomes. 2017 Jun;3:14. DOI: 10.1038/s41522-017-0022-5Search in Google Scholar

36. Amaya M, Tajima M, Okubo Y, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia micro-flora in the lesional skin of psoriasis patients. J Dermatol. 2007 Sep;34(9):619-24. DOI: 10.1111/j.1346-8138.2007.00343.xSearch in Google Scholar

37. Stehlikova Z, Kostovcik M, Kostovcikova K, Kverka M, Juzlova K, Rob F, et al. Dysbiosis of Skin Micro-biota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities. Front Microbiol. 2019 Mar;10:438. DOI: 10.3389/fmicb.2019.00438Search in Google Scholar

38. Rudramurthy SM, Honnavar P, Chakrabarti A, Dogra S, Singh P, Handa S. Association of Malassezia species with psoriatic lesions. Mycoses. 2014 Aug;57(8):483-8. DOI: 10.1111/myc.12186Search in Google Scholar

39. Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 2016 May;55(5):494-504. DOI: 10.1111/ijd.13116Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo